Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1157 of 1,261
  1. US 6709649

    RANTES derived peptides with anti-HIV activity

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR Β· Granted Mar 23, 2004 Β· Expires Mar 18, 2024

    expired
  2. US 6709645

    Synthesis of labeled metabolites

    The Regents of the University of California Β· Granted Mar 23, 2004 Β· Expires Mar 18, 2024

    expired
  3. US 6710166

    41 kDa Cryptosporidium parvum oocyst wall protein

    The United States of America, as represented by the Secretary of Agriculture Β· Granted Mar 23, 2004 Β· Expires Mar 18, 2024

    expired
  4. US 6710053

    Deuterated rapamycin compounds, method and uses thereof

    ISOTECHNIKA INTERNATIONAL INC. Β· Granted Mar 23, 2004 Β· Expires Mar 18, 2024

    expired
  5. US 6710125

    Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics AL, Corporation Β· Granted Mar 23, 2004 Β· Expires Mar 18, 2024

    expired
  6. US 6710073

    Drugs to improve synaptic transmission

    The Regents of the University of California Β· Granted Mar 23, 2004 Β· Expires Mar 18, 2024

    expired
  7. US 6710184

    Crystalline solids of carvedilol and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Mar 23, 2004 Β· Expires Mar 18, 2024

    expired
  8. US 6710034

    5-O-mycaminosyltylonide derivatives

    Enanta Pharmaceuticals, Inc. Β· Granted Mar 23, 2004 Β· Expires Mar 18, 2024

    expired
  9. US 6709858

    Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

    Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Mar 23, 2004 Β· Expires Mar 18, 2024

    expired
  10. US 6709842

    DNA encoding a growth factor specific for epithelial cells

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Mar 23, 2004 Β· Expires Mar 18, 2024

    expired
  11. US 6709830

    Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation

    The Regents of the University of California Β· Granted Mar 23, 2004 Β· Expires Mar 18, 2024

    expired
  12. US 6709837

    Polypeptide and production thereof

    Takeda Chemical Industries Ltd. Β· Granted Mar 23, 2004 Β· Expires Mar 18, 2024

    expired
  13. US 6706509

    Oncoprotein protein kinase

    The Regents of the University of California Β· Granted Mar 16, 2004 Β· Expires Mar 11, 2024

    expired
  14. US 6706732

    Nasal preparation of guanidinoimino quinoline derivatives

    Takeda Chemical Industries Ltd. Β· Granted Mar 16, 2004 Β· Expires Mar 11, 2024

    expired
  15. US 6706719

    Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity

    Darwin Discovery Limited Β· Granted Mar 16, 2004 Β· Expires Mar 11, 2024

    expired
  16. US 6706754

    Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis

    The United States of America as represented by the Secretary of the Army Β· Granted Mar 16, 2004 Β· Expires Mar 11, 2024

    expired
  17. US 6706691

    Immunosupportive drug sparing diet

    The Board of Regents of the University of Texas System Β· Granted Mar 16, 2004 Β· Expires Mar 11, 2024

    expired
  18. US 6706686

    Inhibition of histone deacetylase as a treatment for cardiac hypertrophy

    The Regents of the University of Colorado Β· Granted Mar 16, 2004 Β· Expires Mar 11, 2024

    expired
  19. US 6705556

    Composition and method for inducing tolerance to viral infection in aquatic animals

    First Republic Corporation of America Β· Granted Mar 16, 2004 Β· Expires Mar 11, 2024

    expired
  20. US 6706257

    Sunless tanning products and processes

    Discovery Limited Β· Granted Mar 16, 2004 Β· Expires Mar 11, 2024

    expired
  21. US 6706711

    Pyrazole derived kinase inhibitor

    Vertex Pharmaceuticals Incorporated Β· Granted Mar 16, 2004 Β· Expires Mar 11, 2024

    expired
  22. US 6706873

    Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Mar 16, 2004 Β· Expires Mar 11, 2024

    expired
  23. US 6703016

    Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines

    I.D.M. Immuno-Designed Molecules Β· Granted Mar 9, 2004 Β· Expires Mar 4, 2024

    expired
  24. US 6703424

    Dispersible compositions containing L-DOPA ethyl ester

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Mar 9, 2004 Β· Expires Mar 4, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.